Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Low osmolar oral rehydration salts is a powdered formulation for oral rehydration therapy, containing a specific mixture of **glucose, sodium chloride, potassium chloride, and trisodium citrate dihydrate**. It is designed to be dissolved in one liter of water, creating a solution with a **total osmolarity of 245 mOsm/L**. The solution is used to treat and prevent dehydration caused by diarrheal diseases by leveraging the sodium-glucose cotransport mechanism in the intestines, which enhances water and electrolyte absorption. Compared to the older standard ORS, the low osmolar formulation contains **lower concentrations of sodium chloride and glucose but the same concentrations of potassium and citrate**. This modification reduces stool output, vomiting, and the need for intravenous fluids, especially in children, while maintaining clinical efficacy[1][3][7][10]. Citrate is included as a buffer to correct metabolic acidosis resulting from dehydration[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on low osmolar oral rehydration salts.